Literature DB >> 1778582

Gastric adenocarcinoma in the gastric stump after partial gastrectomy.

J Moreaux, P Mathey, S Msika.   

Abstract

Carcinomas of the gastric stump are divided into two types. In the main group of patients (n = 18), carcinoma developed after resection for benign ulcer disease, and in the second group (n = 4) after resection for early gastric carcinoma. In the first group, the mean age of the patients was 63, and the male-to-female ratio of 17:1. The mean interval between the primary operation and the diagnosis of cancer was 27 years. Biopsies were positive in 16 out of 18 patients. The resectability rate was 72%, resection being performed with curative intent in 50%. Total gastrectomy was performed in 50% of the cases. There were no postoperative deaths. The 5-year survival rate was 33% for all patients and 50% after tumoral resection. Early detection was achieved by means of an endoscopic survey of the gastric stump. A comparison between gastric stump carcinomas and other gastric carcinomas in our series fails to reveal any major differences. Gastric stump carcinoma is not specific. In the second group, the mean age of the patients was 72.5 and the sex ratio 1:1. The mean interval between the two operations was 5 years. The resectability rate was 100%, and all the patients survived with follow-up ranging from 2 to 10 years. The second lesion could be considered a metachronous cancer, but it may have been present and overlooked at the time of the initial gastrectomy. Differentiating between synchronous and metachronous lesions is quite difficult.

Entities:  

Mesh:

Year:  1991        PMID: 1778582

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  8 in total

1.  Endoscopic submucosal dissection for metachronous tumor in the remnant stomach after distal gastrectomy.

Authors:  Jong Yeul Lee; Il Ju Choi; Soo-Jeong Cho; Chan Gyoo Kim; Myeong-Cherl Kook; Jun Ho Lee; Keun Won Ryu; Young-Woo Kim
Journal:  Surg Endosc       Date:  2009-12-09       Impact factor: 4.584

2.  Incidence and treatment of metachronous gastric cancer after proximal gastrectomy.

Authors:  Yoshinori Iwata; Seiji Ito; Kazunari Misawa; Yuichi Ito; Koji Komori; Tetsuya Abe; Yasuhiro Shimizu; Masahiro Tajika; Yasumasa Niwa; Kazuhiro Yoshida; Taira Kinoshita
Journal:  Surg Today       Date:  2018-02-19       Impact factor: 2.549

3.  Clinical significance of tumor location in remnant gastric cancers developed after partial gastrectomy for primary gastric cancer.

Authors:  Ji Yeong An; Ho Geun Youn; Tae Kyung Ha; Min Gew Choi; Kyoung-Mee Kim; Jae Hyung Noh; Tae Sung Sohn; Sung Kim
Journal:  J Gastrointest Surg       Date:  2007-12-13       Impact factor: 3.452

4.  Clinicopathologic features of metachronous or synchronous gastric cancer patients with three or more primary sites.

Authors:  Joo Hoon Kim; Sun Young Rha; Chan Kim; Gun Min Kim; Sang Hyun Yoon; Ki Hyang Kim; Min Jae Kim; Joong Bae Ahn; Hyun Cheol Chung; Jae Kyung Roh; Hyo Song Kim
Journal:  Cancer Res Treat       Date:  2010-12-31       Impact factor: 4.679

5.  Multiple primary malignancies involving lung cancer.

Authors:  Feng Li; Wen-Zhao Zhong; Fei-Yu Niu; Ning Zhao; Jin-Ji Yang; Hong-Hong Yan; Yi-Long Wu
Journal:  BMC Cancer       Date:  2015-10-14       Impact factor: 4.430

6.  The Incidence and Risk Factors for Metachronous Gastric Cancer in the Remnant Stomach after Gastric Cancer Surgery.

Authors:  Yonghoon Choi; Nayoung Kim; Hyuk Yoon; Cheol Min Shin; Young Soo Park; Dong Ho Lee; Young Suk Park; Sang-Hoon Ahn; Yun-Suhk Suh; Do Joong Park; Hyung Ho Kim
Journal:  Gut Liver       Date:  2022-05-15       Impact factor: 4.519

7.  Survival and surgical outcomes of cardiac cancer of the remnant stomach in comparison with primary cardiac cancer.

Authors:  Yi Wang; Chang-Ming Huang; Jia-Bin Wang; Chao-Hui Zheng; Ping Li; Jian-Wei Xie; Jian-Xian Lin; Jun Lu
Journal:  World J Surg Oncol       Date:  2014-01-27       Impact factor: 2.754

Review 8.  Considerations on risk factors correlated to the occurrence of gastric stump cancer.

Authors:  D N Păduraru; A Nica; D Ion; M Handaric; O Andronic
Journal:  J Med Life       Date:  2016 Apr-Jun
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.